Keywords: alcon, expands, accord, origenis, licenses, gsk, cilomilast

Alcon expands R&D accord with Origenis and licenses GSK's cilomilast

Article | 20 October 2008

Print This

Alcon has signed a licensing deal with UK drug major GlaxoSmithKline for global ophthalmic rights to cilomilast, a phosphodiesterase IV ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in